BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 37950803)

  • 1. Therapeutic potential of natural products in inflammation: underlying molecular mechanisms, clinical outcomes, technological advances, and future perspectives.
    Gouda NA; Alshammari SO; Abourehab MAS; Alshammari QA; Elkamhawy A
    Inflammopharmacology; 2023 Dec; 31(6):2857-2883. PubMed ID: 37950803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.
    Dudics S; Langan D; Meka RR; Venkatesha SH; Berman BM; Che CT; Moudgil KD
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-target approach for natural products in inflammation.
    Koeberle A; Werz O
    Drug Discov Today; 2014 Dec; 19(12):1871-82. PubMed ID: 25172801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation.
    Moudgil KD; Venkatesha SH
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal Models of Inflammation for Screening of Anti-inflammatory Drugs: Implications for the Discovery and Development of Phytopharmaceuticals.
    Patil KR; Mahajan UB; Unger BS; Goyal SN; Belemkar S; Surana SJ; Ojha S; Patil CR
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in anti-inflammatory active components and action mechanisms of natural medicines.
    Wu Z; Zhang T; Ma X; Guo S; Zhou Q; Zahoor A; Deng G
    Inflammopharmacology; 2023 Dec; 31(6):2901-2937. PubMed ID: 37947913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human disorders associated with inflammation and the evolving role of natural products to overcome.
    Kishore N; Kumar P; Shanker K; Verma AK
    Eur J Med Chem; 2019 Oct; 179():272-309. PubMed ID: 31255927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Inflammation by Natural Polyphenols: A Comprehensive Mechanistic Update.
    Sarkar S; Mazumder S; Saha SJ; Bandyopadhyay U
    Curr Med Chem; 2016 May; 23(16):1657-95. PubMed ID: 27087243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation.
    Bai R; Yao C; Zhong Z; Ge J; Bai Z; Ye X; Xie T; Xie Y
    Eur J Med Chem; 2021 Mar; 213():113165. PubMed ID: 33454546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products act as game-changer potentially in treatment and management of sepsis-mediated inflammation: A clinical perspective.
    Zhang C; Singla RK; Tang M; Shen B
    Phytomedicine; 2024 Jul; 130():155710. PubMed ID: 38759311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery.
    Li J; Zhao R; Miao P; Xu F; Chen J; Jiang X; Hui Z; Wang L; Bai R
    Eur J Med Chem; 2023 Nov; 260():115791. PubMed ID: 37683361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation: A Multidimensional Insight on Natural Anti-Inflammatory Therapeutic Compounds.
    Dar KB; Bhat AH; Amin S; Masood A; Zargar MA; Ganie SA
    Curr Med Chem; 2016; 23(33):3775-3800. PubMed ID: 27538691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids, inflammation, and fibrosis.
    Zurier RB; Burstein SH
    FASEB J; 2016 Nov; 30(11):3682-3689. PubMed ID: 27435265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: natural products as inhibitors of neuroinflammation.
    Olajide OA; Sarker SD
    Inflammopharmacology; 2020 Dec; 28(6):1439-1455. PubMed ID: 32930914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κβ signaling and chronic inflammatory diseases: exploring the potential of natural products to drive new therapeutic opportunities.
    Killeen MJ; Linder M; Pontoniere P; Crea R
    Drug Discov Today; 2014 Apr; 19(4):373-8. PubMed ID: 24246683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases.
    Ferrer MD; Busquets-Cortés C; Capó X; Tejada S; Tur JA; Pons A; Sureda A
    Curr Med Chem; 2019; 26(18):3225-3241. PubMed ID: 29756563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in discovery and development of natural products as source for anti-Parkinson's disease lead compounds.
    Zhang H; Bai L; He J; Zhong L; Duan X; Ouyang L; Zhu Y; Wang T; Zhang Y; Shi J
    Eur J Med Chem; 2017 Dec; 141():257-272. PubMed ID: 29031072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present Status and Future Trends of Natural-Derived Compounds Targeting T Helper (Th) 17 and Microsomal Prostaglandin E Synthase-1 (mPGES-1) as Alternative Therapies for Autoimmune and Inflammatory-Based Diseases.
    Saviano A; Raucci F; Casillo GM; Indolfi C; Pernice A; Foreste C; Iqbal AJ; Mascolo N; Maione F
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
    Fajardo AM; Piazza GA
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.